Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value: $971M (100.0% shares, 0.0% debt)

Holdings (32)

NUVL NUVALENT INC 15.5%

Value $151M Shares 3,577,267 Est. Cost $28.96 Unrealized +30.5%

NAMS NEWAMSTERDAM PHARMA COMPANY 12.8%

Value $125M Shares 10,473,913 Est. Cost $10.64 Unrealized +24.7%

— SPRINGWORKS THERAPEUTICS INC 8.3%

Value $80.79M Shares 3,081,307 Est. Cost $21.68 Unrealized —

PHVS PHARVARIS N V 7.6%

Value $73.71M Shares 4,868,784 Est. Cost $23.89 Unrealized -59.7%

IRON DISC MEDICINE INC 6.1%

Value $59.17M Shares 1,332,548 Est. Cost $22.28 Unrealized +59.3%

CRNX CRINETICS PHARMACEUTICALS IN 4.3%

Value $41.55M Shares 2,305,558 Est. Cost $18.69 Unrealized +6.7%

SVRA SAVARA INC 3.8%

Value $37.13M Shares 11,622,598 Est. Cost $1.49 Unrealized +58.0%

ACRS ACLARIS THERAPEUTICS INC 3.6%

Value $35.26M Shares 3,400,000 Est. Cost $12.69 Unrealized -28.7%

NTRA NATERA INC 3.5%

Value $34.07M Shares 700,197 Est. Cost $41.20 Unrealized +23.8%

— DYNAVAX TECHNOLOGIES CORP 3.2%

Value $31.2M Shares 2,415,000 Est. Cost $9.83 Unrealized —

— X4 PHARMACEUTICALS INC 3.2%

Value $30.96M Shares 15,960,588 Est. Cost $2.66 Unrealized —

ARQT ARCUTIS BIOTHERAPEUTICS INC 2.9%

Value $28.59M Shares 3,000,000 Est. Cost $26.87 Unrealized -58.7%

— MERSANA THERAPEUTICS INC 2.9%

Value $28.5M Shares 8,663,673 Est. Cost $12.65 Unrealized —

— CYMABAY THERAPEUTICS INC 2.8%

Value $27.38M Shares 2,500,000 Est. Cost $8.72 Unrealized —

CABA CABALETTA BIO INC 2.7%

Value $25.82M Shares 2,000,000 Est. Cost $10.85 Unrealized 0.0%

ANNX ANNEXON INC 2.1%

Value $20.07M Shares 5,701,926 Est. Cost $15.54 Unrealized -71.9%

— EQRX INC 1.9%

Value $18.61M Shares 10,003,573 Est. Cost $6.82 Unrealized —

NRIX NURIX THERAPEUTICS INC 1.9%

Value $18.21M Shares 1,822,883 Est. Cost $21.10 Unrealized -51.7%

SLDB SOLID BIOSCIENCES INC 1.7%

Value $16.4M Shares 3,130,422 Est. Cost $6.55 Unrealized -14.1%

— MARINUS PHARMACEUTICALS INC 1.6%

Value $15.54M Shares 1,431,058 Est. Cost $15.48 Unrealized —

— 2SEVENTY BIO INC 1.5%

Value $14.26M Shares 1,408,901 Est. Cost $18.15 Unrealized —

AVIR ATEA PHARMACEUTICALS INC 1.0%

Value $9.296M Shares 2,485,638 Est. Cost $32.23 Unrealized -88.4%

RPID RAPID MICRO BIOSYSTEMS INC 0.9%

Value $8.435M Shares 8,434,560 Est. Cost $20.66 Unrealized -95.1%

NAUT NAUTILUS BIOTECHNOLOGY INC 0.8%

Value $7.74M Shares 2,000,000 Est. Cost $10.83 Unrealized -73.4%

XLO XILIO THERAPEUTICS INC 0.8%

Value $7.35M Shares 2,805,413 Est. Cost $17.03 Unrealized -82.2%

SYRS SYROS PHARMACEUTICALS INC 0.7%

Value $6.693M Shares 2,124,694 Est. Cost $6.27 Unrealized -48.7%

TNGX TANGO THERAPEUTICS INC 0.7%

Value $6.38M Shares 1,921,790 Est. Cost $11.99 Unrealized -70.0%

CCCC C4 THERAPEUTICS INC 0.5%

Value $4.516M Shares 1,642,210 Est. Cost $29.00 Unrealized -88.9%

— THIRD HARMONIC BIO INC 0.3%

Value $3.081M Shares 640,631 Est. Cost $18.97 Unrealized —

— CARA THERAPEUTICS INC 0.3%

Value $2.646M Shares 934,898 Est. Cost $9.16 Unrealized —

IVVD INVIVYD INC 0.2%

Value $2.034M Shares 1,937,207 Est. Cost $37.11 Unrealized -96.6%

NAMSW NEWAMSTERDAM PHARMA COMPANY 0.0%

Value $209K Shares 100,000 Est. Cost $0.86 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
NUVL	NUVALENT INC	3,577,267	$151M	15.5%	$28.96	+30.5%	COM	670703107
NAMS	NEWAMSTERDAM PHARMA COMPANY	10,473,913	$125M	12.8%	$10.64	+24.7%	ORDINARY SHARES	N62509109
—	SPRINGWORKS THERAPEUTICS INC	3,081,307	$80.79M	8.3%	$21.68	—	COM	85205L107
PHVS	PHARVARIS N V	4,868,784	$73.71M	7.6%	$23.89	-59.7%	COM	N69605108
IRON	DISC MEDICINE INC	1,332,548	$59.17M	6.1%	$22.28	+59.3%	COM	254604101
CRNX	CRINETICS PHARMACEUTICALS IN	2,305,558	$41.55M	4.3%	$18.69	+6.7%	COM	22663K107
SVRA	SAVARA INC	11,622,598	$37.13M	3.8%	$1.49	+58.0%	COM	805111101
ACRS	ACLARIS THERAPEUTICS INC	3,400,000	$35.26M	3.6%	$12.69	-28.7%	COM	00461U105
NTRA	NATERA INC	700,197	$34.07M	3.5%	$41.20	+23.8%	COM	632307104
—	DYNAVAX TECHNOLOGIES CORP	2,415,000	$31.2M	3.2%	$9.83	—	COM NEW	268158201
—	X4 PHARMACEUTICALS INC	15,960,588	$30.96M	3.2%	$2.66	—	COM	98420X103
ARQT	ARCUTIS BIOTHERAPEUTICS INC	3,000,000	$28.59M	2.9%	$26.87	-58.7%	COM	03969K108
—	MERSANA THERAPEUTICS INC	8,663,673	$28.5M	2.9%	$12.65	—	COM	59045L106
—	CYMABAY THERAPEUTICS INC	2,500,000	$27.38M	2.8%	$8.72	—	COM	23257D103
CABA	CABALETTA BIO INC	2,000,000	$25.82M	2.7%	$10.85	0.0%	COM	12674W109
ANNX	ANNEXON INC	5,701,926	$20.07M	2.1%	$15.54	-71.9%	COM	03589W102
—	EQRX INC	10,003,573	$18.61M	1.9%	$6.82	—	COM	26886C107
NRIX	NURIX THERAPEUTICS INC	1,822,883	$18.21M	1.9%	$21.10	-51.7%	COM	67080M103
SLDB	SOLID BIOSCIENCES INC	3,130,422	$16.4M	1.7%	$6.55	-14.1%	COM NEW	83422E204
—	MARINUS PHARMACEUTICALS INC	1,431,058	$15.54M	1.6%	$15.48	—	COM NEW	56854Q200
—	2SEVENTY BIO INC	1,408,901	$14.26M	1.5%	$18.15	—	COMMON STOCK	901384107
AVIR	ATEA PHARMACEUTICALS INC	2,485,638	$9.296M	1.0%	$32.23	-88.4%	COM	04683R106
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$8.435M	0.9%	$20.66	-95.1%	CLASS A COM	75340L104
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$7.74M	0.8%	$10.83	-73.4%	COM	63909J108
XLO	XILIO THERAPEUTICS INC	2,805,413	$7.35M	0.8%	$17.03	-82.2%	COM	98422T100
SYRS	SYROS PHARMACEUTICALS INC	2,124,694	$6.693M	0.7%	$6.27	-48.7%	COM NEW	87184Q206
TNGX	TANGO THERAPEUTICS INC	1,921,790	$6.38M	0.7%	$11.99	-70.0%	COM	87583X109
CCCC	C4 THERAPEUTICS INC	1,642,210	$4.516M	0.5%	$29.00	-88.9%	COM STK	12529R107
—	THIRD HARMONIC BIO INC	640,631	$3.081M	0.3%	$18.97	—	COM	88427A107
—	CARA THERAPEUTICS INC	934,898	$2.646M	0.3%	$9.16	—	COM	140755109
IVVD	INVIVYD INC	1,937,207	$2.034M	0.2%	$37.11	-96.6%	COM	00534A102
NAMSW	NEWAMSTERDAM PHARMA COMPANY	100,000	$209K	0.0%	$0.86	—	*W EXP 11/22/202	N62509117